Sfoglia per RIVISTA
INFECTION AND DRUG RESISTANCE
Collezione ASL Città di Torino

  

Items : 4

Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort. in Infection and drug resistance / Infect Drug Resist. 2020 Jul 14;13:2291-2300. doi: 10.2147/IDR.S260449. eCollection 2020.

2020
ASL Città di Torino

Madeddu G; Dentone C; Colombo V; Celesia BM; Salomoni E; Molteni C; De Socio GV; Squillace N; Menzaghi B; Orofino G; Ricci E; De Vito A; Bonfanti P;

Bone safety of dolutegravir-containing regimens in people living with HIV: Results from a real-world cohort in Infection and Drug Resistance

2020
ASL Città di Torino

Madeddu G; Colombo V; Dentone C; Celesia BM; Salomoni E; De Socio GV; Molteni C; Squillace N; Orofino G; Menzaghi B; Ricci E; De Vito A; Bonfanti P;

Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project. in Infection and drug resistance / Infect Drug Resist. 2019 May 23;12:1385-1391. doi: 10.2147/IDR.S203813. eCollection 2019.

2019
ASL Città di Torino

Bagella P; Squillace N; Ricci E; Gulminetti R; De Socio GV; Taramasso L; Pellicanò G; Menzaghi B; Celesia BM; Dentone C; Orofino G; Bonfanti P; Madeddu G;

Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA Project. in Infection and drug resistance / Infect Drug Resist. 2018 Apr 26;11:615-623. doi: 10.2147/IDR.S152090. eCollection 2018.

2018
ASL Città di Torino

Bagella P; De Socio GV; Ricci E; Menzaghi B; Martinelli C; Squillace N; Maggi P; Orofino G; Calza L; Carenzi L; Celesia BM; Penco G; Di Biagio A; Valsecchi L; Vichi F; Colombo V; Parruti G; Dentone C; Falasca K; Bonfanti P; Madeddu G;